<html><body><table><thead><tr class="rowsep- <span style="color:red" title="HPO: HP:0001510
CONF: 1
PAT: None
NEG: False
REL: False
SECTION: Table File 0" >1 valign-bottom"><th rowspan="2" scope="col"</span> ><strong>ID</strong></th><th rowspan="2" scope="col"><strong>Sex</strong></th><th rowspan="2" scope="col"><strong>Age at Last Visit</strong></th><th scope="col"><strong><em>IARS</em> Mutations</strong></th><th rowspan="2" scope="col"><strong>AO</strong></th><th colspan="4" scope="col"><strong>Clinical Features</strong></th></tr><tr class="rowsep-1 valign-bottom"><th scope="col"><strong>cDNA (NM_002161.5): protein (EAW62813.1)</strong></th><th scope="col"><strong>Growth Retardation (SDS)</strong><a class="workspace-trigger" href="#tblfn1" name="btblfn1"><strong><sup>a</sup></strong></a></th><th scope="col"><strong>Neurological and Cognitive Outcome</strong></th><th scope="col"><strong>Liver Function (Histologic Findings)</strong></th><th scope="col"><strong>Other Features</strong></th></tr></thead><tbody><tr class="valign-top"><td>#65269 (DEU)</td><td>M</td><td>18.7 years</td><td>c. [1252C&amp:gt:T]:[3521T&amp:gt:A]: p.[Arg418<sup>∗</sup>]:[Ile1174Asn]</td><td>prenatal (IUGR)</td><td>yes (−5.9)</td><td>moderate to severe intellectual disability, no expressive speech, spastic movement disorder (GMFCS IV), muscular hypotonia, brain MRI abnormal</td><td>intermittently mildly affected hepatic synthesis (no liver biopsy)</td><td>strabismus, feeding through PEG, esophagitis, zinc deficiency (8.5 μmol/L: N 13–18)<a class="workspace-trigger" href="#tblfn2" name="btblfn2"><sup>b</sup></a></td></tr><tr class="valign-top"><td>#85880 (JPN)</td><td>F</td><td>19 years</td><td>c. [760C&amp:gt:T]:[1310C&amp:gt:T]: p.[Arg254<sup>∗</sup>]:[Pro437Leu]</td><td>prenatal (IUGR)</td><td>yes (−6.2)</td><td>moderate intellectual disability (IQ 50), motor function normal</td><td>elevated ALAT and ASAT, neonatal onset (steatosis, fibrosis)</td><td>sensoneurinal hearing loss (AO 5 years), diabetes mellitus (AO 16 years), epilepsy, zinc deficiency (7.5 μmol/L: N 11–18)<a class="workspace-trigger" href="#tblfn2" name="btblfn2"><sup>b</sup></a></td></tr><tr class="valign-top"><td>#83921 (AUT)</td><td>M</td><td>3 years</td><td>c. [11 <span style="color:red" title="HPO: HP:0001511
CONF: 1
PAT: None
NEG: False
REL: False
SECTION: Table File 0" >09T</span>  <span style="color:red" title="HPO: HP:0001252
CONF: 1
PAT: None
NEG: False
REL: False
SECTION: Table File 0" >&am</span>  <span style="color:red" title="HPO: HP:0001290
CONF: 1
PAT: None
NEG: False
REL: False
SECTION: Table File 0" >p:g</span>  <span style="color:red" title="HPO: HP:0001319
CONF: 1
PAT: None
NEG: False
REL: False
SECTION: Table File 0" >t:G</span>  <span style="color:red" title="HPO: HP:0002719
CONF: 1
PAT: None
NEG: False
REL: False
SECTION: Table File 0" >]:[</span>  <span style="color:red" title="HPO: HP:0001399
CONF: 1
PAT: None
NEG: False
REL: False
SECTION: Table File 0" >297</span>  <span style="color:red" title="HPO: HP:0001397
CONF: 1
PAT: None
NEG: False
REL: False
SECTION: Table File 0" >4A&</span>  <span style="color:red" title="HPO: HP:0003623
CONF: 1
PAT: None
NEG: False
REL: False
SECTION: Table File 0" >amp</span>  <span style="color:red" title="HPO: HP:0000271
CONF: 1
PAT: None
NEG: False
REL: False
SECTION: Table File 0" >:gt</span>  <span style="color:red" title="HPO: HP:0000291
CONF: 1
PAT: None
NEG: False
REL: False
SECTION: Table File 0" >:G]</span>  <span style="color:red" title="HPO: HP:0000293
CONF: 1
PAT: None
NEG: False
REL: False
SECTION: Table File 0" >: p</span>  <span style="color:red" title="HPO: HP:0001396
CONF: 1
PAT: None
NEG: False
REL: False
SECTION: Table File 0" >.[V</span>  <span style="color:red" title="HPO: HP:0004426
CONF: 1
PAT: None
NEG: False
REL: False
SECTION: Table File 0" >al3</span> 70Gly]:[Asn992Asp]</td><td>prenatal (IUGR)</td><td>yes (−6.2)</td><td>moderate intellectual and motor disability, muscular hypotonia</td><td>recurrent liver crises triggered by infections, infantile liver failure, neonatal onset (steatosis, fibrosis, cholestasis)</td><td>peculiar facial distribution of subcutaneous fat (chubby cheeks), feeding through PEG, zinc deficiency (6.1 μmol/L: N 11–15)<a class="workspace-trigger" href="#tblfn2" name="btblfn2"><sup>b</sup></a></td></tr></tbody></table></body></html>